Translational Cancer Mechanisms and Therapy
Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer
Margaret L. Axelrod, Mellissa J. Nixon, Paula I. Gonzalez-Ericsson, Riley E. Bergman, Mark A. Pilkinton, Wyatt J. McDonnell, Violeta Sanchez, Susan R. Opalenik, Sherene Loi, Jing Zhou, Sean Mackay, Brent N. Rexer, Vandana G. Abramson, Valerie M. Jansen, Simon Mallal, Joshua Donaldson, Sara M. Tolaney, Ian E. Krop, Ana C. Garrido-Castro, Jonathan D. Marotti, Kevin Shee, Todd W. Miller, Melinda E. Sanders, Ingrid A. Mayer, Roberto Salgado and Justin M. Balko
Margaret L. Axelrod
1Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Mellissa J. Nixon
1Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Paula I. Gonzalez-Ericsson
2Breast Cancer Research Program, Vanderbilt University Medical Center, Nashville, Tennessee.
Riley E. Bergman
1Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Mark A. Pilkinton
3Department of Infectious Disease, Vanderbilt University Medical Center, Nashville, Tennessee.
Wyatt J. McDonnell
3Department of Infectious Disease, Vanderbilt University Medical Center, Nashville, Tennessee.
Violeta Sanchez
1Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
2Breast Cancer Research Program, Vanderbilt University Medical Center, Nashville, Tennessee.
Susan R. Opalenik
1Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Sherene Loi
4Department of Oncology, University of Melbourne and Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Jing Zhou
5IsoPlexis Corporation, Branford, Connecticut.
Sean Mackay
5IsoPlexis Corporation, Branford, Connecticut.
Brent N. Rexer
1Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Vandana G. Abramson
1Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Valerie M. Jansen
1Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Simon Mallal
3Department of Infectious Disease, Vanderbilt University Medical Center, Nashville, Tennessee.
Joshua Donaldson
1Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Sara M. Tolaney
6Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
Ian E. Krop
6Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
Ana C. Garrido-Castro
6Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
Jonathan D. Marotti
7Department of Pathology & Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
8Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.
Kevin Shee
9Department of Molecular & Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.
Todd W. Miller
8Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.
9Department of Molecular & Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.
Melinda E. Sanders
2Breast Cancer Research Program, Vanderbilt University Medical Center, Nashville, Tennessee.
10Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
Ingrid A. Mayer
1Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
2Breast Cancer Research Program, Vanderbilt University Medical Center, Nashville, Tennessee.
Roberto Salgado
4Department of Oncology, University of Melbourne and Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
11Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium.
Justin M. Balko
1Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
2Breast Cancer Research Program, Vanderbilt University Medical Center, Nashville, Tennessee.
DOI: 10.1158/1078-0432.CCR-19-3685 Published November 2020

Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
November 2020
Volume 26, Issue 21
Volume 26, Issue 21
Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer
Margaret L. Axelrod, Mellissa J. Nixon, Paula I. Gonzalez-Ericsson, Riley E. Bergman, Mark A. Pilkinton, Wyatt J. McDonnell, Violeta Sanchez, Susan R. Opalenik, Sherene Loi, Jing Zhou, Sean Mackay, Brent N. Rexer, Vandana G. Abramson, Valerie M. Jansen, Simon Mallal, Joshua Donaldson, Sara M. Tolaney, Ian E. Krop, Ana C. Garrido-Castro, Jonathan D. Marotti, Kevin Shee, Todd W. Miller, Melinda E. Sanders, Ingrid A. Mayer, Roberto Salgado and Justin M. Balko
Clin Cancer Res November 1 2020 (26) (21) 5668-5681; DOI: 10.1158/1078-0432.CCR-19-3685
Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer
Margaret L. Axelrod, Mellissa J. Nixon, Paula I. Gonzalez-Ericsson, Riley E. Bergman, Mark A. Pilkinton, Wyatt J. McDonnell, Violeta Sanchez, Susan R. Opalenik, Sherene Loi, Jing Zhou, Sean Mackay, Brent N. Rexer, Vandana G. Abramson, Valerie M. Jansen, Simon Mallal, Joshua Donaldson, Sara M. Tolaney, Ian E. Krop, Ana C. Garrido-Castro, Jonathan D. Marotti, Kevin Shee, Todd W. Miller, Melinda E. Sanders, Ingrid A. Mayer, Roberto Salgado and Justin M. Balko
Clin Cancer Res November 1 2020 (26) (21) 5668-5681; DOI: 10.1158/1078-0432.CCR-19-3685
Jump to section
Advertisement